DCs orchestrate a repertoire of immune responses that ranges from tolerance to self-antigens to resistance to infectious pathogens ( 1, 2 ) . In lymph nodes, immature DCs continually present tissue antigens to self-reactive naive T cells, leading to abortive T cell proliferation and establishment of T cell tolerance ( 3 -5 ) . In contrast, mature DCs present microbial antigens and typically induce robust eff ector and memory T cell responses. In the latter case, DC maturation is initiated by microbial products, endogenous danger signals, or signals delivered by antigen-activated T cells, primarily through CD40L ( 6 -8 ) . It is generally believed that full-blown T cell immune responses are dependent on a combination of stimuli derived from microbial products, endogenous danger signals, and feedback from T cells that act in a temporally and spatially ordered fashion to induce DC maturation ( 9, 10 ) . However, it has been shown in some experimental systems that the triggering of CD40, by CD40L expressed on antigen-activated CD4 + T cells or by agonistic antibodies, is suffi cient to license DCs for priming of naive T cells against antigens administered in the absence of adjuvant ( 11 -14 ) .
CD40L is a TNF family member that is rapidly up-regulated on antigen-activated T cells and released by activated platelets, and plays an important role in immune responses by regulating DC and B cell function ( 15 ) . Several studies have reported that CD4 + eff ector and memory T cells contain preformed CD40L in intracellular stores that can be rapidly mobilized to the cell surface after TCR stimulation ( 16 -18 ) . Interestingly, mouse naive CD4 + T cells also constitutively express low amounts of CD40L, which CD40L ( Fig. 1 a ) . In contrast, CD4 + T EM cells homogeneously expressed low amounts of surface CD40L, which was signifi cantly higher compared with naive T and T CM cells ( Fig. 1 a ) . Upon in vitro stimulation with CD3 antibodies, CD40L expression increased in all three subsets, although in T EM cells the kinetics were more rapid and the plateau level was ‫ف‬ 10-fold higher than that reached by naive T or T CM cells ( Fig. 1 b ) . CD40L was also expressed on DO11.10 T EM cells but not on DO11.10 naive or T CM cells (unpublished data). CD40L mRNA was found to be expressed in comparable amounts in T CM and T EM cells (unpublished data), suggesting that the diff erence in protein expression may be caused by diff erences in translation and/or storage. Consistent with this possibility, previous studies showed the presence of prestored CD40L in memory T cells of both human and mouse origin ( 16 -19 ) .
CD4 + naive T, T CM , and T EM cells were then cultured with syngeneic immature BM-derived DCs, and the expression of DC activation markers was measured after 24 h. Although naive T and T CM cells did not induce DC maturation, T EM cells induced up-regulation of CD40, CD86, and MHC class II molecules to an extent comparable to that induced by LPS ( Fig. 1 c ) . DC maturation was also triggered by glutaraldehyde-fi xed CD4 + T EM cells ( Fig. 1 d , top) , indicating that the latter trigger DC maturation in the absence of antigen-dependent or -independent signaling. In addition, CD4 + T EM cells did not induce maturation of CD40 Ϫ / Ϫ DCs ( Fig. 1 d ,  bottom) , indicating that the maturation signal is delivered to DCs through a CD40 -CD40L interaction. Collectively, these data indicate that mouse CD4 + T EM cells, but not naive T or T CM cells, constitutively expressed CD40L at levels suffi cient to trigger in vitro phenotypic maturation of DCs.
CD4 + T EM cell -matured DCs prime naive T cells in vitro
We next asked whether T EM cell -matured DCs would be capable of priming naive T cells. Hemagglutinin (HA) peptidepulsed immature DCs were cultured with CFSE-labeled HA-specifi c 6.5 TCR transgenic CD4 + naive T cells alone or together with naive T, T CM , and T EM cells specifi c for a diff erent antigen (DO11.10 TCR transgenic T cells recognizing OVA). HA-specifi c naive T cells did not proliferate when stimulated with HA-pulsed immature DCs ( Fig. 2 a ) , consistent with the notion that immature DCs have poor co-stimulatory capacity and fail to prime naive T cells ( 26 ) . However, these cells proliferated vigorously and diff erentiated to IFN-␥ -producing eff ector T cells when stimulated with immature DCs in the presence of OVA-specifi c T EM cells but not naive T or T CM cells ( Fig. 2 a and not depicted) . Similarly, CFSElabeled OVA-specifi c CD4 + naive T cells proliferated in response to OVA-pulsed immature DCs when cultured with polyclonal CD4 + T EM cells but not naive T or T CM cells ( Fig.  2 b ) . Finally, in the presence of polyclonal CD4 + T EM cells, OVA-specifi c CD4 + naive T cells proliferated in response to OVA peptide presented by wild-type but not CD40 Ϫ / Ϫ DCs ( Fig. 2 c ) . The results of these in vitro experiments indicate that CD4 + T EM cells can license immature DCs for priming of appears to be suffi cient to induce survival of autoreactive B cells in the absence of T cell activation ( 19 ) . Whether circulating naive or memory T cells may infl uence the DC maturation state in peripheral tissues or lymph nodes through constitutive expression of CD40L remains to be established.
Under steady-state conditions, migration of naive T cells and central memory T (T CM ) cells to peripheral lymph nodes is dependent on the expression of CD62L and CCR7, which mediate interaction with the cognate ligands peripheral node addressin (PNAd) and CCL21, respectively, expressed on high endothelial venules (HEVs) ( 20 ) . Eff ector and eff ector memory T (T EM ) cells, which lack CD62L and CCR7, are largely excluded from resting lymph nodes ( 21 -23 ) . However, we recently demonstrated that CD8 + T EM cells, as well as CCR7 Ϫ NK cells, can effi ciently migrate into lymph node draining sites of injection of mature DCs or adjuvants ( 24, 25 ) . In reactive lymph nodes, CD8 + T EM and NK cells modulate ongoing responses by killing antigen-bearing DCs, thus limiting secondary immune responses, or by producing IFN-␥ , which enhances Th1 polarization. Recruitment of CD8 + T EM and NK cells is dependent on the expression of CXCR3 on migrating cells and coincides with a transient expression of its ligand, CXCL9, on HEVs of reactive lymph nodes ( 24, 25 ) .
In this paper, we report that mouse CD4 + T EM cells, but not naive T or T CM cells, constitutively expressed CD40L at levels suffi cient to trigger phenotypic maturation of DCs and license them for priming of naive CD4 + T cells in vitro and in vivo. We also found that CD4 + T EM cells were largely excluded from resting lymph nodes but migrated in a CD62P-dependent fashion into reactive lymph nodes that were induced to express, in a transient (acute) or sustained (chronic) fashion, CD62P on HEVs. Strikingly, presentation of myelin oligodendrocyte glycoprotein (MOG) peptides by T EM celllicensed DCs in chronic reactive lymph nodes was suffi cient to prime self-reactive T cells, leading to experimental autoimmune encephalomyelitis (EAE).
RESULTS

CD4 + T EM cells constitutively express CD40L and trigger DC maturation
It has been recently reported that naive CD4 + T cells constitutively express CD40L in amounts that are suffi cient to promote autoreactive B cell survival ( 19 ) . We asked whether constitutive expression of CD40L on naive and memory T cell subsets would be suffi cient to induce DC maturation. To generate memory T cells, BALB/c mice were either immunized with KLH in CFA or were adoptively transferred with OVA-specifi c DO11.10 TCR transgenic naive T cells and immunized with OVA-pulsed mature DCs. At least 4 wk after immunization, CD4 + naive T cells (CD44 low , CD62L + , CD127 + ), T CM cells (CD44 high , CD62L + , CD127 + ), and T EM cells (CD44 high , CD62L Ϫ , CD127 + ) were isolated from spleens of BALB/c mice (Fig. S1 , available at http://www.jem.org/ cgi/content/full/jem.20081212/DC1) and stained with antibodies to CD40L. Naive T and T CM cells isolated from KLHimmunized mice did not express detectable levels of surface CXCL9, on HEVs of reactive lymph nodes ( 24, 25 ) . To investigate whether CD4 + T EM cells would be also recruited to reactive lymph nodes, we injected i.v. in vivo -generated OVA-specific memory T cells, comprising both T CM (CD127 + CD62L + ) and T EM (CD127 + CD62L Ϫ ) cells, into syngeneic mice and measured their migration into a reactive lymph node, which had been induced by s.c. injection of LPS-matured DCs, and into a resting lymph node as control ( Fig. 3 a ) . As expected, T CM cells, which represented a minor fraction of the transferred cell population, were highly enriched in resting lymph nodes, accounting for up to 90% of the recruited cells. In contrast, T EM cells were virtually excluded from resting lymph nodes but effi ciently migrated into reactive lymph nodes, where they accounted for up to naive T cells in an antigen-independent and CD40-dependent fashion, and raise the question of whether CD4 + T EM cells might induce DC maturation in vivo.
CD4 + T EM cells rapidly migrate into reactive lymph nodes in a CD62P-dependent, CXCR3-independent fashion Mouse CD4 + and CD8 + T EM cells lack CCR7 and CD62L and are therefore largely excluded from lymph nodes in the steady state ( 21 -23 ) . However, it is increasingly recognized that lymph nodes undergoing an immune response show an increased cellularity and become capable of recruiting CD8 + T EM and NK cells ( 27 ) . Recruitment of CD8 + T EM and NK cells is dependent on expression of CXCR3 on migrating cells and coincides with a transient expression of its ligand, generated in vivo by immunization of wild-type mice and transferred into mice lacking CD62P and CD62E selectins failed to migrate to reactive lymph nodes ( Fig. 3 e ) . Furthermore, migration of T EM cells to reactive lymph nodes of wild-type mice was inhibited by injection of antibodies blocking CD62P but not CD62E ( Fig. 3 f ) . Collectively, these results indicate that recruitment of CD4 + T EM cells into reactive lymph nodes is dependent on CD62P expression on endothelial cells but independent of CXCR3 expression on migrating T cells. The sustained expression of CD62P on HEVs of lymph nodes stimulated by two injections of mature DCs or a single injection of CFA correlated with a signifi cant increase of lymph node cellularity that was sustained for up to 60 d after initial stimulation ( Fig. 4 c and not depicted). In spite of the marked increase in total cell number, the relative proportion of diff erent cell subsets -including CD8 + T, NK, NKT, and B cells, as well as plasmacytoid DCs, dermal DCs, and Langerhans cells -was comparable in resting and DC-reactive lymph nodes, with the only exception being CD4 + T EM cells, which were highly enriched in reactive lymph nodes ( Fig.  4 d ) . Lymph nodes stimulated 30 d earlier with two injections of DCs or one injection of CFA contained signifi cantly higher numbers of endogenous CD4 + CD44 high CD127 + CD62L Ϫ T EM cells compared with resting lymph nodes, or lymph nodes stimulated by one injection of DCs or one or two injections of CpG or LPS ( Fig. 4 e ) . In addition, reactive lymph nodes induced 6 or 30 d before by one or two consecutive injections of LPS-matured DCs recruited i.v.-injected OVA-specifi c T EM cells, indicating that T EM cell migration 85% of the migrated cells, a fi gure similar to that found in the spleen and infl amed peritoneum ( Fig. 3 a ) . Transferred T EM cells were detected in reactive lymph nodes as early as 20 min after i.v. injection ( Fig. 3 b ) , consistent with a direct migration of circulating T cells through HEVs rather than transit from tissues. In addition, 16 h after transfer, T EM cells colocalized with naive T cells in the T cell areas of reactive lymph nodes (Fig. S2 , available at http://www.jem.org/cgi/ content/full/jem.20081212/DC1).
In vivo -generated CD4 + T EM cells homogeneously expressed CXCR3, the receptor for CXCL9, a chemokine expressed on HEVs of reactive lymph nodes, and P-selectin glycoprotein ligand 1, the ligand for CD62P/CD62E expressed on endothelial cells and platelets ( Fig. 3 c ) ( 28 ) . To investigate the requirements for CXCR3 in the process of CD4 + T EM cell migration to reactive lymph nodes, T EM -like cells (96% CD62L negative) were generated in vitro from wild-type and CXCR3-defi cient mice, mixed at a 1:1 ratio, and injected i.v. into mice carrying a reactive lymph node induced by s.c. injection of LPS-matured DCs. Surprisingly, wild-type and CXCR3-defi cient T cells were recovered in similar proportions in spleens and reactive lymph nodes ( tion, the number of T EM cells in reactive lymph nodes decreased substantially (Fig. S3 b) , indicating that T EM cells continually recirculate from blood to lymph node and from there to efferent lymph. We conclude that expression of CD62P on the luminal side of HEVs of reactive lymph nodes can be induced in a transient or sustained fashion depending on the nature of the eliciting stimulus, and coincides with increased lymph node cellularity, which was caused by a uniform increase of all major cell subsets and a much higher increase of CD4 + T EM cells.
into reactive lymph nodes is not dependent on the presence of a specifi c antigen (Fig. S3 a, available at http://www.jem.org/ cgi/content/full/jem.20081212/DC1).
The increased number of T EM cells found in reactive lymph nodes 30 d after injection of DCs or CFA may result from an increase in resident T EM cells or may depend on a continuous recruitment of T EM cells from the blood. To distinguish between these possibilities, we injected antibodies to CD62P, which, as shown in Fig. 3 f , block T EM cell recruitment into reactive lymph nodes. Within a few hours after antibody injec- cgi/content/full/jem.20081212/DC1), suggesting that T cells may be required for the establishment and/or maintenance of chronic reactive lymph nodes. When wild-type mice were injected with antibodies to CD62P that prevent migration of T EM cells into reactive lymph nodes ( Fig. 3 f ) , the increase in We also investigated the role of T cells in induction and maintenance of reactive lymph nodes. When CFA was injected s.c. in CD3 Ϫ / Ϫ mice, cell numbers in draining lymph nodes increased on day 2, but this increase was not sustained at later time points (Fig. S4 a, In another experimental set up, we measured the proliferative response of naive T cells in the presence of adoptively transferred T EM cells ( Fig. 5 g ). Mice transferred with CFSElabeled HA-specifi c 6.5 naive T cells received a s.c. injection of LPS to induce a reactive lymph node. On day 5 after LPS injection, some mice were also transferred with OVA-specifi c T EM cells, which had been either untreated or treated with anti-CD40L antibodies and then challenged i.v. with HA in PBS. HA-specifi c T cells failed to proliferate in LPS-treated mice, consistent with our preliminary observation that the adjuvant eff ect of LPS is rapidly lost in vivo (unpublished data). In contrast, HA-specifi c T cells proliferated in lymph nodes containing T EM cells but not CD40L antibody -treated T EM cells ( Fig. 5 h ) . Of note, treatment of CD4 + T EM cells with anti-CD40L antibodies did not prevent their migration into reactive lymph nodes (unpublished data). Collectively, these results indicate that CD4 + T EM cells migrating into chronic reactive lymph nodes act as an antigen-nonspecifi c endogenous adjuvant by continuously triggering DC maturation in a CD40L-dependent fashion and facilitating T cell immune responses to otherwise nonimmunogenic antigens.
Induction of EAE in reactive lymph nodes in the absence of adjuvants
The fi ndings described in the previous section raise the possibility that in chronic reactive lymph nodes, CD4 + T EM cells may license DCs for priming of autoreactive T cells. To test this possibility, we induced reactive lymph nodes by two consecutive injections of mature DCs or a single injection of CFA, and 1 mo later challenged the mice by s.c. injection of MOG peptides in PBS at sites draining into the reactive lymph node. Control mice were injected with MOG peptide in PBS or CFA. The clinical score of EAE was recorded in a blinded fashion by two researchers. In addition, brains and spinal cords were collected at the end of the experiments and analyzed for the presence of infi ltrating CD4 + T cells.
Injection of MOG peptide in CFA led to rapid development of clinical symptoms of EAE and to accumulation of CD4 + T cells in the central nervous system, whereas injection of MOG peptide in PBS did not result in any clinical symptoms or T cell infi ltrate ( Fig. 6, a and b ) . Remarkably, injection of MOG peptide in PBS in mice carrying a reactive lymph node, which had been induced by injection of either CFA or mature DCs 1 mo earlier, led to the development of clinical symptoms and T cell infi ltrates that were comparable in severity and extent to those induced by the administration of MOG in CFA ( Fig. 6, c and d ) . Pretreatment of mice with anti-CD62P antibodies did not interfere with EAE induced by immunization with MOG peptide in CFA ( Fig. 6 a ) , consistent with the fact that CD62P is not required for migration of eff ector T cells into the brain ( 29 ) . Remarkably, however, anti-CD62P treatment prevented EAE and T cell infi ltration in the central nervous system induced by injection of MOG peptide in PBS draining into reactive lymph nodes ( Fig. 6,  c and d ) . Collectively, these data are consistent with a model in which CD4 + T EM cells recruited into reactive lymph nodes lymph node cellularity was almost entirely prevented (Fig. S4 b) , consistent with the possibility that T EM cells migrating in a CD62P-dependent fashion are required for long-term maintenance of chronic reactive lymph nodes.
CD4 + T EM cells in lymph node license DCs for T cell priming
The fi nding that under certain conditions recruitment of T EM cells in lymph nodes can be sustained for several weeks suggests the possibility that these cells might infl uence the DC maturation state through the constitutive expression of CD40L. To test this possibility, mice were transferred with Thy1.1 + OVA-specifi c DO11.10 naive T cells and primed with one or two consecutive s.c. injections of OVA-pulsed DCs (OVA-DC 1 × and OVA-DC 2 × , respectively) to generate T EM cells and to induce an acute or a chronic reactive lymph node ( Fig. 5 a ) . Some mice were injected weekly with anti-CD62P blocking antibodies or isotype-matched control antibodies to inhibit T EM cell migration and the induction of chronic reactive lymph nodes. 30 d after priming, high numbers of DO11.10 T EM cells were recovered from chronic reactive but not acute reactive lymph nodes (Fig. S5 , available at http:// www.jem.org/cgi/content/full/jem.20081212/DC1). Interestingly, on day 30 after priming all DCs recovered from chronic reactive lymph nodes expressed increased levels of CD40 and MHC class II molecules as compared with DCs recovered from resting or acute reactive lymph nodes ( Fig. 5 b ) . At this late time point, there was no evidence of persisting OVA antigen in reactive lymph nodes, as shown by the lack of proliferation of i.v.-injected CFSE-labeled OT-II T cells (unpublished data). Strikingly, in mice treated with blocking CD62P antibodies, DCs did not show increased expression of CD40 and MHC class II molecules ( Fig. 5 b ) . These results are consistent with a role for lymph node -migrating CD4 + T EM cells in the induction of DC maturation in vivo.
We next asked whether T EM cell -matured DCs in chronic reactive lymph node would be capable of priming naive T cells to an antigen administered in the absence of adjuvant. Mice treated as above were adoptively transferred on day 30 with CFSE-labeled HA-specifi c 6.5 naive T cells and challenged by i.v. injection of HA in PBS ( Fig. 5 c ) . As expected, no proliferative response was observed in control mice in response to HA administered in the absence of adjuvants. In addition, HA-specifi c T cells did not proliferate in mice in which a transient reactive lymph node was induced by a single injection of DCs (1 × ). In contrast, a strong proliferative response of HA-specifi c T cells was observed in chronic reactive lymph nodes induced by two injections of DCs (2 × ) and containing OVA-specifi c T EM cells. Strikingly, HA-specifi c T cells did not proliferate in mice chronically treated with CD62P antibodies, which blocked T EM cell migration into lymph nodes and DC maturation ( Fig. 5 c and Fig. S5 ). Comparable results were obtained in mice in which a reactive lymph node was induced by injection of CFA and that did not receive DO11.10 T cell transfer ( Fig. 5, d -f ) , suggesting that CFA-induced T EM cells emerging from the endogenous repertoire are suffi cient to induce DC maturation and T cell priming. suggested to allow for CD62P-dependent homing of CD62L-defi cient leukocytes ( 31 ) .
CD62P expression is known to be induced on the endothelial cells of infl amed peripheral tissues and to regulate recruitment of eff ector cells of the innate and adaptive immune system ( 32 ). Previous studies have shown that under conditions of intravital microscopy (but not in situ), CD62P can be expressed on HEVs of Peyer ' s patches and subiliac lymph nodes and can account for residual migration of leukocytes in the absence of CD62L or ␤ 7-integrins ( 33, 34 ) . CD62P was also reported to be expressed at low levels on HEVs in the course of experimental mouse listeriosis ( 35 ) . Our results show for the fi rst time that CD62P is induced in peripheral lymph node HEVs by s.c. injection of adjuvants or mature DCs and that it can mediate migration of CD4 + T EM cells. Intriguingly, CD62P expression on HEVs can be acute or chronic, depending on the nature of the eliciting stimuli. Although soluble TLR agonists (LPS, CpG, and R848) or a single injection of mature DCs induced a transient expression of CD62P (up to day 6), a single injection of CFA or two consecutive injections, 2 d apart, of mature DCs led to an up-regulation of CD62P that was sustained for > 60 d. Importantly, the persistence of CD62P on HEVs correlates with increased lymph node cellularity, recruitment of T EM cells, and increased immunostimulatory capacity of lymph node -resident DCs. Although the eff ect of CFA may be explained by a sustained release of microbial products from a tissue depot, it remains to be established how two injections of mature DCs, which are known to be short lived, may induce a long-lasting change in the draining lymph node in the apparent absence of residual antigen, as shown by the fi nding that 30 d after injection of OVA-pulsed DCs, CFSE-labeled OVA-specifi c T cells failed to proliferate (unpublished data).
We have provided evidence that T cells may be required for maintenance of chronic reactive lymph nodes. Indeed, although the initial increase of cell number in lymph nodes stimulated by adjuvants or mature DCs can be induced in T cell -defi cient CD3 Ϫ / Ϫ mice, the sustained increase in lymph node cellularity is dependent on the presence of T cells. The fi ndings that antibodies to CD62P prevented migration of T EM cells and increased lymph node cellularity would be consistent with a role for these cells in the development of chronic reactive lymph nodes. However, at this point we cannot rule out the possibility that cells other than T EM cells requiring CD62P to enter lymph node might also be involved. In addition, it is possible that other changes besides sustained expression of CD62P may take place in reactive lymph nodes. For instance, innate stimuli have been shown to promote remodeling of the primary feed arteriole, leading to an increase in lymphocyte input ( 36 ) . It is tempting to speculate that, once the inducing stimulus has reached a suffi cient threshold, the reactive state of the lymph node may be maintained by irreversible structural changes or by continuous recruitment of T EM and/or innate immune cells.
Another major fi nding of this study is that CD4 + T EM cells constitutively express CD40L at levels suffi cient to trigger DC provide a licensing signal to resident DCs that facilitates response to self-antigens and the development of pathogenic autoreactive T cells.
DISCUSSION
We have shown that CD4 + T EM cells, which migrate with low effi ciency into resting lymph nodes, migrate in a CD62P-dependent fashion into reactive lymph nodes that have been induced to express, in a transient or sustained manner, CD62P on HEVs. In reactive lymph nodes, CD4 + T EM cells trigger maturation of DCs in an antigen-independent fashion via constitutively expressed CD40L and license them for T cell priming against antigens, including self-antigens, administered in the absence of exogenous adjuvants.
We previously reported that, after s.c. injection of adjuvants or mature DCs, draining lymph nodes become capable of attracting leukocytes, such as CD8 + T EM and NK cells, that are largely excluded from resting lymph nodes ( 24, 25 ) . Entry of CD8 + T EM and NK cells requires expression of CXCR3 on migrating cells and coincides with expression of the cognate chemokines on HEVs of reactive lymph nodes. Although the ligand for CD62P is expressed on CD8 + eff ector T cells, this adhesion molecule is not required for homing of CD8 + T cells to reactive lymph nodes, as demonstrated by experiments using specifi c blocking antibodies (unpublished data). The present study shows that migration of CD4 + T EM cells into reactive lymph nodes occurs through a diff erent mechanism independent of CXCR3 and dependent on CD62P. This conclusion is based on the fi ndings that wildtype and CXCR3-defi cient CD4 + T EM cells showed a comparable capacity to migrate into reactive lymph nodes, and that CD4 + T EM cell migration was not observed in mice lacking CD62P/E and could be inhibited by antibodies against CD62P but not CD62E. In addition, migration of CD4 + T EM cells in lymph nodes coincides with expression of CD62P on HEVs that was induced, in an acute or chronic fashion, by adjuvants or mature DCs. Interestingly, chronic reactive lymph nodes did not appear to effi ciently recruit cytotoxic CD8 + T EM cells as acute lymph nodes do ( 25 ) , indicating that entry of these cells is restricted to the early phases of an immune response.
A recent study demonstrated that antigen-primed lymph nodes contain a resident population of antigen-specific CXCR5 + ICOS + follicular helper T cells ( 30 ) . In contrast to follicular helper T cells, the CD4 + T EM cells described in this paper continually recirculate through the reactive lymph nodes because they disappeared rapidly when entry was blocked by injection of CD62P antibodies. It remains to be established which lymphocyte integrin is involved in this process and whether chemokine-dependent activation of integrins is required, because the high amounts of LFA-1 and ␣ 4-integrins expressed on memory T cells may promote effi cient adhesion of rolling cells even in the absence of chemokine signaling. In addition, one should consider the possibility that CD62P-expressing platelets adhering to HEVs may facilitate extravasation of P-selectin glycoprotein ligand 1 + T EM cells, as it has been CD62P antibodies, which blocked T EM cell migration into reactive lymph nodes, inhibited both DC maturation and T cell priming. The effi ciency of CD4 + T EM cells in inducing DC maturation may rely on the anatomy of the lymph node, which places extravasating T EM cells in direct contact with DCs, and on the high numbers and motility of T EM cells, and hence, their ability to interact with multiple DCs in a serial fashion ( 38 ) . Although our results indicate that DC maturation and licensing is selectively induced by T EM cells but not by naive or T CM cells, we cannot rule out the possibility that constitutive expression of CD40L on the latter may contribute to DC survival and function. Indeed, CD40L on mouse naive maturation and to license them for T cell priming ( 37 ) . Constitutive CD40L expression was signifi cantly higher in T EM cells as compared with naive or T CM cells, and only T EM cells, but not naive or T CM cells, triggered DC maturation and promoted T cell priming in vitro in an antigen-independent and CD40-dependent fashion. Importantly, this eff ect was also observed in vivo. DCs in chronic reactive lymph nodes, exposed to recirculating CD4 + T EM cells, homogeneously expressed high levels of MHC and co-stimulatory molecules and were able to trigger naive T cell proliferation in response to antigens administered in the absence of adjuvants. The critical role of T EM cells was demonstrated by the fact that injection of DCs and cell transfer. BM-derived DCs were generated as previously described ( 54 ) by culturing BM precursors from femurs of mice in RPMI 1640 medium supplemented with 10% (vol/vol) FCS, 1% (vol/vol) Glutamax, 1% (vol/vol) nonessential amino acids, 1% (vol/vol) pyruvate, 50 U/ml penicillin, 50 μ g/ml streptomycin (all from Invitrogen), and 50 μ g/ml 2-mercaptoethanol (Merck) in the presence of recombinant GM-CSF (R & D Systems). DC maturation was induced by overnight incubation with 0.5 μ g/ml LPS (Sigma-Aldrich). Whole spleen cells were labeled with 0.3 or 2.5 μ M CFSE (Invitrogen) or with 10 μ M 5-and 6-(4-chloromethyl)benzoyl-aminotetramethylrhodamine (Invitrogen). For in vivo blocking experiments, purifi ed anti-CD62L, anti-CD62P, anti-CD62E, or isotype control antibodies (all from BD Biosciences) were injected i.v (100 μ g per mouse). These experiments were performed either before or after transfer of fl uorescently labeled cells and before or after injection of DCs, as indicated in the fi gures.
Immunization. The following proteins and peptides were used: whole OVA protein was obtained from Sigma-Aldrich and KLH was obtained from EMD; purifi ed HA of infl uenza A/IVR116 (H1N1) virus was a gift of G. Galli (Novartis, Siena, Italy); and OVA 323-339 (ISQAVHAAHAEINEAGR), HA 110-119 (SFERFEIFPK), and MOG (MEVGWYRSPFSRVVH-LYRNGK) peptides were synthesized by the Servei de Prote ò mica (Pompeu Fabra University, Barcelona, Spain). For immunization with adjuvant, 50 μ g of whole protein was emulsifi ed in CFA (DIFCO) and injected s.c. in the fl ank. Where indicated in the fi gures, immunization was performed i.v. with 10 μ g OVA or HA in PBS. 3 -4 wk after priming, CD4 + T cells were enriched from spleen and peripheral lymph nodes with CD4 magnetic beads (Miltenyi Biotec) and sorted using a FACSAria (BD Biosciences) according to the expression of CD44, CD62L, and CD127. Transgenic Thy1.1 + DO11.10 CD4 + T cells were purifi ed from spleen and lymph nodes and labeled with 2.5 μ M CFSE, and 10 6 cells were injected i.v. into syngeneic hosts. Adoptively transferred mice received one (DC 1 × ) or two consecutive (2 d apart; DC 2 × ) s.c. injections of 10 6 OVA-loaded, LPS-matured DCs. 3 -4 wk after priming, DO11.10 CD4 + T cells were enriched from spleen and lymph nodes by cell sorting according to the expression of CD44, CD62L, and CD127 (T CM , CD44 high CD62L + CD127 + ; T EM , CD44 high CD62L Ϫ CD127 + ). Naive T cells (CD44 low CD62L + CD127 + ) were purifi ed from spleens of Rag2 Ϫ / Ϫ DO11.10 mice. CD4 + naive T, T CM , and T EM cells were adoptively transferred into syngeneic hosts or used in vitro, as indicated in the fi gures. Reactive lymph nodes were in some experiments induced by s.c. injection of LPS, CpG 1826 oligodeoxynucleotide (5 Ј -CCATGACGTTCCTGACGTT-3 Ј ; Microsynth), IFA (DIFCO), or CFA. Peritonitis was induced by an i.p. injection of a 3% solution (wt/vol) of thioglycolate (Sigma-Aldrich) in PBS.
In vitro experiments. Naive antigen-specifi c CD4 + T cells were primed in vitro with immature or with LPS-matured DCs pulsed with the peptides indicated in the fi gures (T cell/DC ratio = 10:1). CD4 + naive T, T CM , or T EM cells specifi c for a diff erent antigen were added to these cultures. Polyclonal and OT-II CD4 + T cells were primed in vivo, and 3 wk later T EM CD4 + T cells were sorted as before and expanded in vitro with 10 μ g/ml each of anti-CD3 and anti-CD28 (both from BD Biosciences). On day 4, cultures were supplemented with 10 U/ml of human recombinant IL-2 ( 55 ), and cells were collected 7 -9 d later. To measure surface expression of CD40L, CD4 + T cells were activated in vitro with soluble 10 μ g/ml anti-CD3 (BD Biosciences) and 10 ng/ml phorbol-12,13 dibutyrate (PDBu; Sigma-Aldrich). At the time points after stimulation indicated in the fi gures, cold PBS containing 5% FCS was added to the cells. Immature BM-DCs were prepared and co-cultured in vitro with naive or in vivo -generated T CM or T EM CD4 + T cells. DCs were analyzed for expression of CD40, CD86, T cells has been shown to be suffi cient to promote survival of autoreactive B cells ( 19 ) .
Microbial products have been shown to be required to break tolerance to tissue antigens, leading to autoimmunity ( 39 ) . In addition, LPS may activate autoreactive CD4 + cells in a bystander fashion ( 40 ) . Based on our fi ndings, we hypothesized that the DC licensing eff ect exerted by CD40L + CD4 + T EM cells traffi cking into reactive lymph nodes may facilitate immune responses to poorly immunogenic antigens, such as tissue antigens, in the apparent absence of microbial products. This possibility was demonstrated by the fi nding that EAE could be induced by injection of a MOG peptide at a site draining into the chronic reactive lymph node accessible to circulating antigen-nonspecific T EM cells. Although endogenous danger signals, such as ATP or uric acid ( 41 ) , may play a synergistic role in the priming of autoreactive T cells, the fi nding that the mere exclusion of T EM cells form the reactive lymph nodes by CD62P antibody treatment was suffi cient to prevent immuno pathology points to T EM cells as the primary inducing factor in eliciting this pathogenic response. Although it is premature to envisage a role for CD40L constitutively expressed on CD4 + T EM cells in induction of autoimmune diseases, it is of note that increased levels of CD40L-expressing eff ector and memory T cells have been observed in autoimmune-prone mice ( 17 ) and in human memory T cells of patients with multiple sclerosis ( 42 -44 ) , and targeting the CD40 -CD40L interaction has been proposed as a treatment for autoimmune diseases or to induce allograft tolerance ( 45, 46 ) . In addition, activated CD4 + T cells have been shown to prime and expand endogenous autoreactive CD8 + T cells in an antigen-dependent or -independent fashion through the licensing of DCs via CD40L ( 47, 48 ) . We found that clinical symptoms and the extent of T cell infi ltration were comparable in mice immunized with MOG in CFA or with soluble MOG draining into a reactive lymph node. It remains to be established whether these distinctive priming environments generate a comparable spectrum of polarized eff ector T cells ( 49 ) .
In conclusion, our study provides evidence for a mechanistic link between changes in cell traffi c in lymph nodes and predisposition to mount eff ector responses to otherwise nonimmunogenic antigens. We are currently testing the possibility that induction of chronic reactive lymph nodes at sites that drain tumor antigens may facilitate priming of eff ector T cells against the tumor. medium, and layered onto a Lympholyte-M density gradient (Cedarlane). Tubes were centrifuged at room temperature for 20 min at 800 g . Viable lymphocytes were removed from the interface.
MATERIALS AND METHODS
Mice
Statistical analysis. Data, presented as means ± SD, were analyzed with a paired Student ' s t test using the SPSS software (v16). P < 0.05 was considered signifi cant.
Online supplemental material. Fig. S1 shows the sorting strategy for T naive, T CM , and T EM cells. Fig. S2 shows that adoptively transferred naive T and T EM cells localized in the same area in reactive lymph nodes. Fig. S3 shows that T EM cell migration into the reactive lymph node is not dependent on the presence of specifi c antigen, and that T EM cells do not represent a resident population in reactive lymph nodes. Fig. S4 shows that T cells may be required for induction of chronic reactive lymph nodes. Fig. S5 shows the absolute number of DO11.10 T EM cells in chronic reactive lymph nodes in the experiment in Fig. 5 .
